Fluorescence microscopy image of HAV-infected cultured human liver cell. viral RNA targeted by ZCCHC14 appears green, and the virus’s protein red. Credit: Maryna Kapustina, UNC School of Medicine
Scientists Discover Key to Hepatitis A Virus Replication, Show Drug Effectiveness
With no current treatments for hepatitis A, scientists at the University of North Carolina School of Medicine led by Stanley M. Lemon, MD, discovered how a protein and enzymes interact to allow hepatitis A virus to proliferate, and they used a known drug to stop viral replication in an animal model.
The viral replication cycle is essential for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), University of North Carolina (UNC) School of Medicine scientists discovered that replication requires particular interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases. They also discovered that the oral compound RG7834 stopped viral replication at a key step, preventing liver cell infection.
These findings are the first to demonstrate an effective drug treatment against HAV in an animal model of the disease. The study was published today (July 4, 2022) in the Proceedings of the National Academy of Sciences.
Continue reading… “Scientists Discover First Effective Drug Treatment Against Hepatitis A”
